Storm brews around Aduhelm as FDA re­quests probe; Dis­sect­ing pipeline dis­as­ters; Bob Nelsen is go­ing Re­al­ly Big; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

As the bio­phar­ma in­dus­try booms, man­u­fac­tur­ing drugs in the quan­ti­ty and qual­i­ty re­quired are be­com­ing in­creas­ing­ly cru­cial. If you’re in­ter­est­ed in track­ing the lat­est de­vel­op­ments in that space, Kyle Blanken­ship and Josh Sul­li­van have you cov­ered in the week­ly End­points Man­u­fac­tur­ing re­port. Check out the chan­nel here and vis­it your read­er pro­file to re­ceive it in your in­box next Thurs­day.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.